IFITM proteins inhibit the late step of feline foamy virus replication

References

• Ballana E, Esté JA. 2015. SAMHD1: at the crossroads of cell proliferation, immune responses, and virus restriction. Trends Microbiol. 23:680–692. doi: 10.1016/j.tim.2015.08.002
   PubMed Web of Science ®Google Scholar
• Coffin JM, Hughes SH, Varmus HE. 1997. Retroviruses. Cold Spring Harbor (NY): Cold Spring Harbor Laboratory Press.
   Google Scholar
• Gorman MJ, Poddar S, Farzan M, Diamond MS. 2016. The interferon-stimulated gene IFITM3 restricts West Nile virus infection and pathogenesis. J Virol. 90:8212–8225. doi: 10.1128/JVI.00581-16
   PubMed Web of Science ®Google Scholar
• Hamann MV, Lindermann D. 2016. Foamy virus protein-nucleic acid interactions during particle morphogenesis. Viruses. 8:243. doi: 10.3390/v8090243
   Web of Science ®Google Scholar
• Huang IC, Bailey CC, Weyer JL, Radoshitzky SR, Becker MM, Chiang JJ, Brass AL, Ahmed AA, Chi X, Dong L, et al. 2011. Distinct patterns of IFITM-mediated restriction of filoviruses, SARS coronavirus, and influenza A virus. PLoS Pathog. 7:e1001258. doi: 10.1371/journal.ppat.1001258
   PubMed Web of Science ®Google Scholar
• Jia R, Ding S, Pan Q, Liu SL, Qiao W, Liang C. 2015. The C-terminal sequence of IFITM1 regulates its anti-HIV-1 activity. PLoS One. 10:e0118794. doi: 10.1371/journal.pone.0118794
   PubMed Web of Science ®Google Scholar
• Lee WJ, Fu RM, Liang C, Sloan RD. 2018. IFITM proteins inhibit HIV-1 protein synthesis. Sci Rep. 8:14551. doi: 10.1038/s41598-018-32785-5
   PubMed Web of Science ®Google Scholar
• Lee GE, Kim J, Shin CG. 2019. Single residue mutation in integrase catalytic core domain affects feline foamy viral DNA integration. Biosci Biotechnol Biochem. 83:270–280. doi: 10.1080/09168451.2018.1530969
   PubMed Web of Science ®Google Scholar
• Lilly F. 1970. Fv-2: identification and location of a second gene governing the spleen focus response to friend leukemia virus in mice. J Natl Cancer Inst. 45:163–169.
   PubMed Web of Science ®Google Scholar
• Lindermann D, Rethwilm A. 2011. A foamy virus biology and its application for vector development. Viruses. 3:561–585. doi: 10.3390/v3050561
   PubMed Web of Science ®Google Scholar
• Löchelt M, Muranyi W, Flügel RM. 1993. Human foamy virus genome possesses an internal, Bel-1-dependent and functional promoter. Proc Natl Acad Sci USA. 90:7317–7321. doi: 10.1073/pnas.90.15.7317
   PubMed Web of Science ®Google Scholar
• Muñoz-Moreno R, Cuesta-Geijo MÁ, Martínez-Romero C, Barrado-Gil L, Galindo I, García-Sastre A, Alonso C. 2016. Antiviral role of IFITM proteins in African swine fever virus infection. PLoS One. 11:e0154366. doi: 10.1371/journal.pone.0154366
   PubMed Web of Science ®Google Scholar
• Narayana SK, Helbig KJ, McCartney EM, Eyre NS, Bull RA, Eltahla A, Lloyd AR, Beard MR. 2015. The interferon-induced transmembrane proteins, IFITM1, IFITM2, and IFITM3 inhibit hepatitis C virus entry. J Biol Chem. 290:25946–25959. doi: 10.1074/jbc.M115.657346
   PubMed Web of Science ®Google Scholar
• Ranjbar S, Haridas V, Jasenosky LD, Falvo JV, Goldfeld AE. 2015. A role for IFITM proteins in restriction of Mycobacterium tuberculosis infection. Cell Rep. 13:874–883. doi: 10.1016/j.celrep.2015.09.048
   PubMed Web of Science ®Google Scholar
• Smith SE, Busse DC, Binter S, Weston S, Soria CD, Laksono BM, Clare S, Nieuwkoop SV, Hoogen BGV, Clement M, et al. 2019. Interferon-induced transmembrane protein 1 restricts replication of viruses that enter cells via the plasma membrane. J Virol. 93:e02003–18. doi: 10.1128/JVI.02003-18
   PubMed Web of Science ®Google Scholar
• Wang Y, Pan Q, Ding S, Wang Z, Yu J, Finzi A, Liu SL, Liang C. 2017. The V3 loop of HIV-1 env determines viral susceptibility to IFITM3 impairment of viral infectivity. J Virol. 91:e02441–16. doi: 10.1128/JVI.02441-16
   PubMed Web of Science ®Google Scholar
• Xie M, Xuan B, Shan J, Pan D, Sun Y, Shan Z, Zhang J, Yu D, Li B, Qian Z. 2015. Human cytomegalovirus exploits interferon-induced transmembrane proteins to facilitate morphogenesis of the virion assembly compartment. J Virol. 89:3049–3061. doi: 10.1128/JVI.03416-14
   PubMed Web of Science ®Google Scholar